The reaction of 6-hydrazinyl-1,3-dimethylpyrimidine-2,4-(1H,3H)-dione (1) with ethoxymethylenemalononitrile afforded 5-amino-1-(1,3-dimethyl-2,6-dioxo-1,2,3,6-tetrahydropyrimidin-6-yl)-1H-pyrazole-4-carbonitrile (2). The latter was reacted with formamide and urea affording the corresponding 4-aminopyrazolo[3,4-d]pyrimidines 3 and 4. The reaction of monosaccharide aldoses with 3 and 4 gave stereoselectively the β-N-glycosides 5a -d and 6a -d which were treated with acetic anhydride in pyridine to afford the corresponding acetylated derivatives 7a -d and 8a -d. The prepared compounds were tested for their antiviral activity against hepatitis B virus (HBV) and showed moderate to high activities.
Introduction
Pyrazole and pyrimidine derivatives attracted organic chemists very much due to their biological and chemotherapeutic importance. Pyrazolopyrimidines and related fused heterocycles are of interest as potential bioactive molecules. They are known to exhibit pharmacological activities such as CNS-depressant (Abdou et al., 2004; Julino and Stevens, 1998) , antiviral (Gadhachanda et al., 2007) anticancer (Capdeville et al., 2002; Taylor et al., 1992; Al-Saadi et al., 2008) and tuberculostatic (Ghorab et al., 2004) activities. Pyrazolo [3,4-d] pyrimidines were identifi ed as a general class of adenosine receptors (Davies et al., 1983 (Davies et al., , 1984 . Furthermore, some pyrazolo [3,4-d] pyrimidine derivatives demonstrated signifi cant antiviral activity (Anderson et al., 1990; Rashad et al., 2008) . There is not much difference in the basic structures of pyrazolopyrimidines and purines (Holla et al., 2006) . On the other hand, glycosyl amines (Ellis and Honeyman, 1955; Kuhn, 1957; Durette et al., 1978; Katzen, 1979; Cascieri et al., 1979; Danishefsky and Allen, 2000) are important because these occur as junctures in glycoproteins (Kent, 1967; Hughes, 1973) . The chemical and structural nature of the derivatives formed by the reaction of a monosaccharide and different nitrogen bases depends upon the reaction conditions and the base used (Ojala et al., 2000) . N-Glycosyl amines ( Fig. 1 ) have advantage over their saccharide counterparts in binding to metal ions, as these compounds provide additional binding centres. In view of such important aspects of N-glycosyl amines (Ali et al., 2007a) and our interest in the synthesis of biologically active glycosides (ElSayed et al., 2008; Ali et al., 2007b ) the aim of the present work was the synthesis and anti-hepatitis B virus evaluation of different N-glycosyl amines of simple saccharides using 4-aminopyrazolo[3,4-d]-pyrimidines as amines.
Experimental

General
Melting points were determined using a Büchi apparatus. IR spectra (KBr) were recorded with a Bruker-Vector22 instrument (Bruker, Bremen, Germany). 1 H NMR spectra were recorded with a Varian Gemini spectrometer at 300 MHz and 200 MHz with TMS as internal standard. Chemical shifts were reported in δ scale (ppm) relative to TMS as a standard, and the coupling constants (J values) are given in Hz. The progress of the reactions was monitored by TLC using aluminum silica gel plates 60 F 245 . EI-mass spectra were 4(1H, 5 g of the carbonitrile 2 and 10 mL formamide were heated at 180 -190 ºC for 30 min. The cooled solution was diluted with 100 mL ice-cold water, and the precipitate obtained was fi ltered to yield 3.1 g of the crude product 3. The product was purifi ed by dissolving it in 10% HCl, the insoluble part was removed by fi ltration. The fi ltrate was taken and the pH value was adjusted to 8 with concentrated ammonium hydroxide. This solution was allowed to cool to 10 -15 ºC. Then it was fi ltered, washed with water to afford 3 in a pure form. Yield: 2.5 g (45%). -6-oxo-6,7-dihydropyrazolo[3,4- 
6-(4-Amino
5 g of the carbonitrile 2 and 10 g urea were heated at 180 -185 ºC for 10 min. The resulting solid was dissolved in dilute sodium hydroxide and then carefully acidifi ed with acetic acid to obtain 3.9 g of crude product 4. Further purifi cation was accomplished by reprecipitation from dilute sodium hydroxide with acetic acid. Yield: 3.0 g (51%).
General procedure for the synthesis of the N
4 -β-D-glycosides 5a -d and 6a -d A solution of the respective sugar (5 mmol) in ethanol (5 mL) was treated with 3 or 4 (5 mmol) in ethanol (40 mL) and glacial acetic acid (0.1 mL). The mixture was heated under refl ux for 2 h (control by TLC). The solid, which separated out on cooling, was fi ltered, washed with ethanol, and crystallized from ethanol to afford 5a -d in 80 -85% and 6a -d in 78 -83% yields.
General procedure for the synthesis of the
, dry pyridine (3 mL), and acetic anhydride (3 mL) was stirred for 15 min at 0 ºC, then kept overnight at room temperature (r.t.) with stirring. The mixture was poured onto crushed ice (30 g); and the precipitate was collected by fi ltration, washed repeatedly with water, dried, and recrystallized from ethanol/ water (2:8, v/v) to afford 7a -d in 95 -98% and 8a -d in 96 -97% yields.
Antiviral activity
The synthesized compounds were tested for their antiviral activity against hepatitis B virus (HBV) using the HepG2.2.2.15 cell line (Sells et al., 1987) , a human hepatoplastoma cell line producing HBV viral particles (Korba and Gerin, 1992) .
The cell line was maintained in RPMI-1640 (Glutamax) (Gibco BRL Life Technologies, Paisly, Scotland) culture medium containing 100 IU/mL nystatin (Gibco BRL Life Technologies), 380 µg/mL G418 (genetecin) (Gibco BRL Life Technologies) and 10% fetal calf serum (FCS) (Gibco BRL Life Technologies). The transferred HEPG2.2.2.15 cells were kept in a tissue culture fl ask at 37 ºC and 5% CO 2 . Subcultures were set up after a week by trypsination [10% versin/ trypsin (Biochrome KG, Berlin, Germany)] and transferred to a 96-well tissue culture plate. Serial dilutions of the test compounds were added to the cell suspension and incubated for 6 d at 37 ºC and 5% CO 2 . The antiviral activity and cytotoxic effect of the test compounds were estimated by comparing the DNA content in the culture supernatant and the viability of the cells with the test compounds added to those of HepG2.2.2.15 cells with no compounds added to their supernatant (blank cells). The drug lamivudine [4-amino-1-[(2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl]-1,2-dihydropyrimidin-2-one (GlaxoSmithKline, Uxbridge, UK)] which is a potent selective inhibitor of HBV replication has been used as a standard positive control. Each compound was tested in triplicate.
DNA extraction
DNA extraction was done by incubating 10 µL of diluted supernatant with 10 µL of 0.2 M NaOH at 37 ºC for 1 h, then carefully adding 9.6 µL of 0.2 M HCl followed by addition of 90 µL of Tris-EDTA (TE) buffer [2-amino-2-(hydroxymethyl)-1,3-propanediol-EDTA (Gibco BRL Life Technologies)].
PCR-ELISA detection of HBV DNA
The DNA content of the cell culture supernatant was determined by PCR amplifi cation of the HBV DNA using 1 µmol/L of each of the primers HCID-1 (5′-GGAAAGAAGTCA G A A-GGCA-3′) and HCID-2 (5′-TTGGGGGAGGA-GATTAGGTT-3′), in a reaction mixture containing 14 µL extracted supernatant, 4 mmol/L MgCl 2 , 10 µmol/L DIG-11-dUTP (Roche, Munich, Germany), 190 µmol/L dTTP, 200 µmol/L dATP, dGTP, dCTP (Roche), 1.5 U Taq polymerase (Roche), in a total volume of 50 µL. PCR reaction conditions were: 32 cycles of 10 min at 94 ºC, 30 s at 58 ºC and 30 s at 72 ºC, with a 3-s increment for each cycle, in a Perkin Elmer 480 thermal cycler (Perkin Elmer, Waltham, MA, USA). The PCR product was detected by DIG-ELISA assay (Roche). The optical density (OD) of DNA of the test compound was compared to that of the blank culture.
Cytotoxicity assay
3-(3,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) (Sigma, St. Louis, MO, USA) is a colourless substrate that is transferred to a coloured product by any living cell but not by dead cells. The assay utilizes this compound to test for the viability of the cells with the test compound added compared to the viability of the blank cells (Fouad et al., 1998) .
Calculation of IC 50 , CC 50 , and SI values
The 50% inhibitory concentration (IC 50 ) of an antiviral drug is determined by plotting the DNA content of the serial dilutions of the tested compound versus the concentration of this compound. The 50% cytotoxic effect (CC 50 ) is calculated from 
Results and Discussion
Chemistry
In the present investigation, 6-hydrazinyl-1,3-dimethylpyrimidine-2,4-(1H,3H)-dione (1) (Pfl eiderer and Schündehütte, 1958) was condensed with ethoxymethylenemalononitrile in ethanol at refl ux temperature to afford 5-amino-1-(1,3-dimethyl-2,6-dioxo-1,2,3,6-tetrahydropyrimidin-6-yl)-1H-pyrazole-4-carbonitrile (2) in 65% yield.
The structure of the produced carbonitrile was proved by its spectral data; IR, 1 H NMR and mass spectra were in agreement with the assigned structure. The IR spectrum showed characteristic absorption bands at 3450 cm -1 (NH 2 ) and 2225 cm -1 (CN). The 1 H NMR spectrum showed a signal at δ 6.99 ppm, a broad singlet, integrating for two protons and indicating the presence of an NH 2 group in the pyrazole ring (which disappeared in D 2 O); all aromatic proton signals exactly matched the structure. The formation of carbonitrile 2 was also confi rmed by recording its mass spectrum. 66%), which is in accordance with its molecular formula.
Compound 2 was reacted with formamide and urea to afford 6-(4-amino-1H-pyrazolo[3,4-d]-pyrimidin-1-yl)-1,3-dimethylpyrimidine-2,4-(1H,3H)-dione (3) and 6-(4-amino-6-oxo-6,7-dihydropyrazolo[3,4-d] pyrimidin-1-yl)-1,3-dimethylpyrimidine-2,4(1H,3H)-dione (4), respectively (Fig. 1) . The formation of the pyrimidines was confi rmed by recording their spectra. Thus, the 1 H NMR spectrum of 3 showed a signal at δ 7.37 ppm corresponding to the NH 2 peak, and all other peaks exactly matched the structure. In the IR spectrum, the absence of a CN peak indicated that the cyclization was completed. The mass spectrum of 3 also confi rmed the formation of the molecule. The structure of compound 4 was also confi rmed by recording its spectra. Condensation of 3 and 4 with a number of monosaccharides (D-glucose, D-galactose, D-ribose, and D-xylose) in boiling ethanol and in the presence of a catalytic amount of glacial acetic acid gave stereoselectively 4-(β-D-glycopyranosylamino)pyrazolo [3,4-d] pyrimidines 5a -d in 80 -85% yields and 6a -d in yields of 78 -83% (Fig. 2) . In the 1 H NMR spectra of 5a -d and 6a -d the anomeric protons appeared as doublet in the range δ 7.10 -7.15 ppm with J (1,2) = 8.0 Hz. This value is consistent with the β-confi guration of 4 C 1 (D) conformation (Gorin and Mazurek, 1975; Abdel-Megeed et al., 1995) . The reaction of 5a -d and 6a -d with acetic anhydride in pyridine at room temperature (r.t.) led to the acetylation of sugar hydroxy groups, without affecting the NH group, to give the tri-and tetraacetoxy-β-D-glycosides 7a -d in yields of 95 -98% and 8a -d in 96 -97% yields. The IR spectra of 7a -d and 8a -d are characterized by two absorption bands at 3380 -3395 and 1745 -1755 cm -1 indicating the presence of OAc and NH groups. In addition, the 1 H NMR spectra showed triplets at low fi eld at δ 5.10 -5.20 ppm assigned as H-1', with J (1,2) = 9.0 Hz, which confi rmed the expected β-confi guration of 4 C 1 (D) conformation (Fig. 2) .
Antiviral testing
The synthesized compounds were tested for their antiviral activity against hepatitis B virus (HBV) using the HepG2.2.2.15 cell line, a human hepatoplastoma cell line producing HBV viral particles (Korba and Gerin, 1992) . The results of our preliminary screening indicated that compounds 5a, 5b, 6a, and 6b showed the highest inhibitory activity among this series of tested compounds with an effective inhibitory concentration of 0.2 µM and a selectivity index > 500.0, followed by compounds 5c, 5 d, 6c, and 6 d. Compounds 7a -d and 8a -d showed moderate inhibitory activity with moderate cytotoxicity, while the other tested compounds 2 -4 exhibited less activity against HBV (Table I) .
From the results of the viral inhibition tests and structure-activity relationship, we conclude that the glycosyl amine residues attached to the pyrazolo [3,4-d] pyrimidine derivatives increase the antiviral activity against HBV. Moreover, the free hydroxy N-glycosyl amine derivatives of pyrazolo [3,4-d] pyrimidines showed higher inhibitory activity than the corresponding acetylated derivatives. 
